Health Condition 1: L659- Nonscarring hair loss, unspecified
Conditions
Interventions
Intervention1: Platelet rich plasma therapy and 2% minoxidil combination: Plasma is first extracted from the venous blood from which the platelets are then concentrated by the method of centrifugation
Sponsors
LADY HARDINGE MEDICAL COLLEGE
Eligibility
Inclusion criteria
Inclusion criteria: 1. Females aged 18-55 years with a clinical and trichoscopic diagnosis of FPHL. 2. Ludwig score 1-3, all patterns of FPHL. 3. Females giving consent for photography of the scalp.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating females. 2. Known case of polycystic ovarian disorder (PCOD) or presence of clinical signs suggestive of PCOD. 3. H/o oopherectomy, autoimmune or endocrinological disorder (Cushings/Addisons disease), platelet disorders, bleeding disorders, malignancy or keloidal tendency. 4. History of any treatment for hair loss in the past 90 days (oral/topical hair growth boosters/hormonal therapy/anticancer drugs or steroids). 5. Any active scalp infection. 6. Pregnant Patients with positive viral markers (HIV 1 and 2, Hepatitis B & C) or otherwise immunocompromised .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative assessment of the proportion of patients with patient satisfaction score more than 6Timepoint: at 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?? Comparative assessment of the following parameters in the two groups. 1. Mean change in hair density from baseline to 6 months 2. Proportion of patients showing improved hair density on global photography. 3. Proportion of patients showing negative hair pull test at the end of 6 months. 4. Percentage of patients showing side effects of PRP therapy. Timepoint: Day 0, 4th, 8th, 12th, 20th and 24th week. | — |
Countries
India
Contacts
Public ContactDr Vibhu Mendiratta
LADY HARDINGE MEDICAL COLLEGE
Outcome results
None listed